Atrial Flutter with 1:1 Atrioventricular Conduction
Keywords:
urogenital abnormality, anorectal malformation, , Creatinine, Electrolytes, Urea., Biochemical parameters, dengue patients, serum albumin, serum ALT, Indigenous Knowledge, traditional medicine (tm), herbs, nso, bakweri, efficacy, inefficacy, traditional healers, herbal remedies, medical anthropology., Arrhythmia, Atrial flutter, Vagal maneuvers, Electrical cardioversiAbstract
Introduction: Generally, atrial flutter leads 2:1 to the ventricles. It rarely leads 1:1, with states of cardiogenic shock. Due to the very fast ventricular rate.
Objetives: To present patients with atrial flutter, with 1:1 atrioventricular conduction. Explain diagnostic methods. Review production mechanisms. Define the causes of presentation in exposed. patients. Mention the behavior and treatment.
Methods: The following were taken in to account: Electrocardiogram with heart rate greater tan Identification of atrial flutter waves. Determination of 1:1 atrioventicular conduction. Typing of heart disease. Evaluation of hemodynamic status. Age and sex. Then we proceded to treatment and behavior.
Results: Ten patients were observed. Average age 57 (22-72). Ischemic heart disease 4; chronic rheumatic 2; chronic cor pulmonale 2; dilated cardiomyopathy 1 and pre-excitation syndrome 1. Average atrial rate 257 (240-270). Hemodynamic instablity 6. Treatment: electrical cardioversión 5; Amiodarone 2; Digoxin 1; descontinuation of Digoxin 1 and spontaneous 1. Vagal maneuver was performed in 5. Digoxin precipitated the arrhythmia in 1,in the rest it was triggered spontaneously.
Conclusion: The mayority of cases had heart disease. The arrhythmia can be confused with ventricular tachycardia and paroxismal supraventricular tachycardia. Vagal maneuvers help in the diagnosis. Depending on the state of hemodynamic stability, it card be treated with antiarrhythmics or electrical cardioversión.
References
M. Cardenas (1976) Clínica de las arritmias. 216.
J. Granada, W. Uribe, P. Chyou (2000) Incidence and predictors of atrial flutter in the general population. 36, 2242.
F. Sarnago, A. Almazan, M. Margil (1978) Estudio clínico y electrocardiográfico del flutter auricular. (148), 147.
M. Cardenas, F. Amezcua (1962) Aspectos clínicos del flutter auricular. 62, 283.
R. Lavadenz, R. Villanueva (1983) Flutter auricular, etiología, clínica y electrocardiografía. 14, 27.
T. Lavadenz, G. Pereira (1994) Arritmias cardíacas. Frecuencia y características en un Hospital General. 11, 17.
P. Iturralde (1997) Arritmias cardíacas. 131.
N. Fowler (1980) Arritmias cardíacas. Diagnóstico y tratamiento. 92.
S. Bellet (1972) Essentials of cardiac arrhythmias. 56.
R. Lavadenz (1990) Diagnóstico y tratamiento de las arritmias cardíacas. 111.
B. Lown, S. Levine (1961) The carotid sinus. Clinical value if its stimulation. 23, 766.
M. Kawabata, K. Hirao, K. Higuchi (2008) Clinical and electrophysiologic characteristics patients having atrial flutter with 1:1 atrioventricular conduction. 10, 284.
A. Vereckei (2014) Current algorithms for the diagnosis of wide complex tachycardias. 10, 262.
K. Lee, Y. Yang, M. Scheinman (2005) Atrial flutter. A review of its history, mechanisms, clinical features and current therapy. 30, 121.
Gutierrez Duke M, H. Matiz (2006) Electrofisiología celular y arritmias cardíacas. 170.
A. Slade, C. Garrat (1993) Proarrhythmic effect of adenosine in a patient with atrial flutter. 70, 91.
Y. Watanabe, L. Dreifus (1979) Arritmias cardíacas. Bases electrofisiológicas para la interpretación clínica. 69.
M. Van den Berg, H. Crinjs, B. Szabo (1995) Effect of exercise on cycle length in atrial flutter. 73, 263.
A. Rankin, A. Rae, A. Houston Acceleration of ventricular response to atrial flutter after intravenous Adenosine.
M Riva, J Montero, R Salgado, et al. (2012) Flutter auricular 1:1, tras la administración de Vernakalant para la cardioversión de fibrilación auricular. 65, 1054.
T Colangelo, D Johnson, R Ho (2021) Flecainide induced atrial flutter 1:1 conduction, complicated by ventricular fibrillation, after electrical cardioversion. 48(No.2).
C Robertson, H Miller (1980) Extreme tachycardia, complicating the use Disopyramide in atrial flutter. 44, 602.
A Nabar, L Rodriguez, C Timmermans, et al. (2001) Class IC antiarrhythmic drug induced atrial flutter. Electrocardiographic and electrophysiological findings and importance and for long term outcome after right atrial isthmus ablation. 85, 424.
M Brodsky, B Allen, J Grimes, et al. (1994) Enhanced atrioventricular conduction during atrial flutter, after intravenous Adenosine. 330, 288.
P Franquelo, C Canales, J Viñas, et al. (2012) Un paciente. Con flutter IC. 5, 59.
J Merce, A Torrens, M Juan, et al. (2019) Flutter auricular 1:1 conducido con aberrancia en una paciente tratada con Flecainida. 4, 121.
S Robinet, P Melon, L Pierard (2007) Flutter auriculaire avec response ventriculaire rapide (conduction auriculo-ventriculaire (1:1) lors d'un traitement par flecainide. 62, 701.
F Cosio, E Delpon (2002) New Antiarrhythmic drugs for atrial flutter and atrial fibrillation. 105, 276.
S Dardas, A Khan (2021) Atrial flutter with Flecainide-induced 1:1 conduction at a rate < 200 b.p.m at rest. A case report. 5(1).
C Falces, J Brugada, J Barreto, et al. (1996) Conducción auriculoventricular 1:1 transitoria, en un paciente con flutter auricular común, tras la administración de trifosfato de Adenosina. 49, 767.
R Burkhart, G Gerasimon (2018) Atrial flutter with exercise-induced 1:1 atrioventricular conduction. 118, 337.
B Nigussie, F Abaleka, M Suhail, et al. (2020) Diagnosis and management of 1:1 atrial flutter in the setting of aortic valve endocarditis and embolic stroke. 12, e8739.
M Turfan, S Turkoglu, M Ozdemir, et al. (2008) Atrial flutter with 1:1 conduction in a 70-year-old man with hyperthiroidism. 15, 555.
A Murthy, A Jain, H Tan (2013) A not so benign atrial flutter: spontaneous 1:1 conduction of atrial flutter.
J Brugada, D Katritsis, A Arbelo (2020) 2019 ESC guidelines for the management of patients with Supraventricular tachycardia. 41, 665.
R Sosa, M Arce (2019) Aleteo auricular con conducción auriculoventricular 1:1. Descripción de un caso. 1.
M Cereceda, R Asenjo (2003) Taquicardia de complejo ancho, insuficiencia cardíaca descompensada y hepatitis aguda alcohólica. 22, 71.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
